Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Headache, Immunisation, Nasal congestion
Clinical narrative: Despite the vaccine and booster, I contracted COVID-19. Early symptoms included sore throat, headache, body aches, and fever, but these gave way to cough and congestion after a few days. I tested nega; Despite the vaccine and booster, I contracted COVID-19. Early symptoms included sore throat, headache, body aches, and fever, but these gave way to cough and congestion after a few days. I tested nega; Despite the vaccine and booster, I contracted COVID-19. Early symptoms included sore throat, headache, body aches, and fever, but these gave way to cough and congestion after a few days. I tested nega; Despite the vaccine and booster, I contracted COVID-19. Early symptoms included sore throat, headache, body aches, and fever, but these gave way to cough and congestion after a few days. I tested nega; Despite the vaccine and booster, I contracted COVID-19. Early symptoms included sore throat, headache, body aches, and fever, but these gave way to cough and congestion after a few days. I tested nega; Despite the vaccine and booster, I contracted COVID-19. Early symptoms included sore throat, headache, body aches, and fever, but these gave way to cough and congestion after a few days. I tested nega; Despite the vaccine and booster, I contracted COVID-19. Early symptoms included sore throat, headache, body aches, and fever, but these gave way to cough and congestion after a few days. I tested nega; Despite the vaccine and booster, I contracted COVID-19. Early symptoms included sore throat, headache, body aches, and fever, but these gave way to cough and congestion after a few days. I tested nega; Despite the vaccine and booster, I contracted COVID-19. Early symptoms included sore throat, headache, body aches, and fever, but these gave way to cough and congestion after a few days. I tested nega; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old female patient (not pregnant) received bnt162b2 (COMIRNATY), administered in arm left, administration date 20Oct2021 (Lot number: FF8841) at the age of 26 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLU, administration date 16Oct2021; SRONYX. Vaccination history included: Comirnaty (Dose Number: 2, Batch/Lot No: EN5318, Location of injection: Arm Left), administration date: 19Feb2021, when the patient was 26 years old, for COVID-19 immunization; Comirnaty (Dose Number: 1, Batch/Lot No: EN5318, Location of injection: Arm Left), administration date: 29Jan2021, when the patient was 26 years old, for Covid-19 Immunization. The following information was reported: IMMUNISATION (medically significant) with onset 20Oct2021, outcome "unknown", VACCINATION FAILURE (medically significant), COVID-19 (medically significant), OROPHARYNGEAL PAIN (non-serious), HEADACHE (non-serious), PAIN (non-serious), PYREXIA (non-serious), COUGH (non-serious), NASAL CONGESTION (non-serious) all with onset 31Dec2021 20:00, outcome "recovering" and all described as "Despite the vaccine and booster, I contracted COVID-19. Early symptoms included sore throat, headache, body aches, and fever, but these gave way to cough and congestion after a few days. I tested nega". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Sep2021) negative, notes: Nasal Swab; (01Jan2022) negative, notes: Nasal Swab; (27Dec2021) negative, notes: Nasal Swab; (21Sep2021) negative, notes: Nasal Swab; (04Jan2022) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19, oropharyngeal pain, headache, pain, pyrexia, cough, nasal congestion.  Clinical course: The patient had not received any AE treatment and no covid prior vaccination. No past drug event. No Known allergies. Other medical history: No. Tested negative in an at-home test, then positive in a PCR test.  No follow-up attempts are possible. No further information is expected.